Skip to content

Evaluation of the clinical efficacy and mechanism of Liangshi decoction in the prevention and treatment of myopia

Evaluation of the clinical efficacy and mechanism of Liangshi decoction in the prevention and treatment of myopia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000502
Enrollment
Unknown
Registered
2024-09-29
Start date
2024-10-08
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

Experimental group:Health education + optometry + Liangshi prescription

Sponsors

Eye Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1) Age: 6-14 years old; 2) Equivalent Spherical(SE): -6.00D<SE=-0.50D (between 50 and 600 degrees, both eyes included); 3) Refractive error =1.5D; 4) Astigmatism =1.5D; 5) Corrected visual acuity = 1.0; 6) TCM diagnosis of Spleen Qi Deficiency; 7) Agree to participate in the trial, with informed consent signed by the legal guardian and the person himself/herself respectively.

Exclusion criteria

Exclusion criteria: 1) Other eye diseases that affect vision; 2) Serious systemic diseases; 3) Patients with strabismus and amblyopia; 4) Both parents or one parent with high myopia (equivalent spherical lens <-6.00DS) in one or both eyes; 5) Being using other methods or participating in other studies; 6) Use of antibiotics, probiotics, intestinal cleansing products, or proton pump inhibitors within 1 month prior to study entry; 7) Other binocular contraindications, etc.

Design outcomes

Primary

MeasureTime frame
Half a year myopia progression control amount;

Secondary

MeasureTime frame
Axial growth rate;Best uncorrected distance visual acuity;TCM syndrome scores;corneal curvature;Half a year myopia progression control amount;subjective visual quality;

Countries

China

Contacts

Public ContactZefeng Kang

Eye Hospital, China Academy of Chinese Medical Sciences

kangzf7717@126.com13552597717

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026